SPONSOR
Atridia Pty Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1
NCT06830850 Phase 1
Recruiting
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration Resistant Prostate Cancer
NCT07390747 Phase 1
Recruiting
A Trial of SHR-2173 in Healthy Volunteers
Immunology